Circadian Orchestration of the Hepatic Proteome  by Reddy, Akhilesh B. et al.
Current Biology 16, 1107–1115, June 6, 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2006.04.026Report
Circadian Orchestration
of the Hepatic ProteomeAkhilesh B. Reddy,1,* Natasha A. Karp,2
Elizabeth S. Maywood,1 Elizabeth A. Sage,2
Michael Deery,2 John S. O’Neill,1 Gabriel K.Y. Wong,1
Jo Chesham,1 Mark Odell,3,4 Kathryn S. Lilley,2
Charalambos P. Kyriacou,3 and Michael H. Hastings1
1Medical Research Council
Laboratory of Molecular Biology
Hills Road
Cambridge CB2 2QH
United Kingdom
2Cambridge Centre for Proteomics
University of Cambridge
Cambridge CB2 1QW
United Kingdom
3Department of Genetics
University of Leicester
Leicester LE1 7RH
United Kingdom
Summary
Circadian rhythms are essential to health. Their dis-
ruption is associated with metabolic diseases in ex-
perimental animals and man [1–3]. Local metabolic
rhythms represent an output of tissue-based circadian
clocks [4]. Attempts to define how local metabolism is
temporally coordinated have focused on gene expres-
sion by defining extensive and divergent ‘‘circadian
transcriptomes’’ involving 5%–10% of genes assayed
[5–8]. These analyses are inevitably incomplete, not
least because metabolic coordination depends ulti-
mately upon temporal regulation of proteins [9, 10].
We therefore conducted a systematic analysis of
a mammalian ‘‘circadian proteome.’’ Our analysis re-
vealed that up to 20% of soluble proteins assayed in
mouse liver are subject to circadian control. Many of
these circadian proteins are novel and cluster into dis-
crete phase groups so that the liver’s enzymatic profile
contrasts dramatically between day and night. Unex-
pectedly, almost half of the cycling proteins lack a cor-
responding cycling transcript, as determined by quan-
titative PCR, microarray, or both and revealing for the
first time the extent of posttranscriptional mecha-
nisms as circadian control points. The circadian pro-
teome includes rate-limiting factors in vital pathways,
including urea formation and sugar metabolism.
These findings provide a new perspective on the ex-
tensive contribution of circadian programming to he-
patic physiology.
*Correspondence: areddy@cantab.net
4 Present address: Department of Molecular and Applied Bio-
science, University of Westminster, London W1W 6UW, United
KingdomResults
Analysis of the Circadian Proteome of the Liver
We analyzed the mouse liver proteome across circadian
time by two-dimensional difference gel electrophoresis
(2D-DIGE) by using tissue harvested from groups of
mice on the second cycle after transfer from synchro-
nized (12L:12DR, i.e., 12 hr light:12 hr dim red light) to
free-running conditions (DR:DR, i.e., constant dim red
light). Proteins were extracted from each liver individu-
ally, and equal amounts were pooled from six mice per
4 hr time point. Across the matrix of 2D-DIGE analyses,
642 protein ‘‘spots’’ were reliably detected. To count in
the detection, the spots had to be present in more than
75% of the gels and have a ‘‘spot volume’’ R 5 3 104
as determined by the analysis software (see the Sup-
plemental Experimental Procedures available with this
article online). Of these consistently detected proteins,
60 (i.e., 9.4%) exhibited highly significant (p < 0.01)
circadian variation, as shown by analysis of variance
(ANOVA). With ANOVA set at p < 0.05, 135 (i.e., 21%)
of these spots exhibited a significant temporal change
[11]. Thus, we estimate that up to 20% of robustly ex-
pressed soluble liver proteins are under circadian regu-
lation, a notable advance on previous estimates that the
circadian transcriptome incorporates between 5% and
10% of genes assayed [5–8].
We selected the 60 rhythmic spots identified with
highest stringency (p < 0.01) for collection and identifi-
cation either by using peptide mass fingerprinting
(MALDI-TOF mass spectrometry) or by generating unin-
terpreted peptide fragmentation data by using liquid
chromatography followed by tandem mass spectrome-
try (LC-MS/MS) and using the Mascot search engine
(see Supplemental Experimental Procedures). Of these
60, 39 spots could be identified and were shown to cor-
respond to the products of 29 different genes because in
some cases several distinct spots represented multiple
isoforms of the same protein (see Table S2 in the Sup-
plemental Data for an annotated list). A second analysis
of an independent series of liver samples obtained at
CT11, 23, and 35 allowed us to identify a further ten
rhythmic proteins from ten genes. When multiple iso-
forms were taken into consideration, we established a fi-
nal list of 39 unique genes for which the corresponding
49 protein products were rhythmic. Expression of these
novel circadian proteins fell into a range of phase group-
ings, and overall ten peaked during the subjective day,
whereas 39 were distributed in two clusters that were
most abundant during the subjective night (Figures 1A
and 1B).
The Molecular Clock Controls Circadian
Protein Expression
As a technical and biological validation of our novel cir-
cadian proteins identified with 2D-DIGE and MS, we as-
sayed expression of a subset of them by using immuno-
blotting of liver tissue from further, independent sets of
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1109wild-type and circadian mutant tissues. Our choice of
targets was dictated by the availability of reliable, pre-
validated antisera for candidate proteins. Bmal1 acted
as a positive control for circadian protein expression
and exhibited a clear 24 hr cycle in liver from wild-type
animals (n = 6 per time point), with protein levels peaking
in the subjective night (Figure 2A). Aldolase and Cata-
lase were also expressed rhythmically and, consistent
with the 2D-DIGE analyses, levels were highest during
circadian night. In contrast, Arginase, which was identi-
fied as a daytime protein by 2D-DIGE, was also rhythmic
but had an earlier phase than the other proteins. Thus,
Western blot analyses revealed clear rhythmicity for
three candidates identified as rhythmic by 2D-DIGE
analyses, independently confirming their circadian ex-
pression and validating the procedure.
Rhythmic protein abundance in the liver is likely de-
pendent upon the local molecular clockwork. We there-
fore tested whether genetic disruption of normal circa-
dian patterning affected rhythmic expression of the
three novel circadian proteins. As a control, in indepen-
dent liver samples taken from wild-type mice at CT0, 6,
12, and 18, there was again clear circadian variation in
the levels of Bmal1, Aldolase, and Catalase (Figures
2B and 2C), and consistent with 2D-DiGE, Arginase ex-
pression was also rhythmic and phase advanced rela-
tive to the other proteins. However, in livers from clock
mutant mice [12, 13], the daily rhythms in expression
of both Bmal1 and the novel circadian proteins were dis-
rupted (Figure 2B). Furthermore, in heterozygous
mPer2ldc mutant mice, which show normal circadian be-
havior [14], the target proteins were expressed rhythmi-
cally as in wild-type animals, whereas in arrhythmic ho-
mozygous mutants rhythmic protein expression was
abrogated (Figure 2C). To pursue the impact of this
per2 mutation further, DiGE was used to compare pro-
tein expression in livers from heterozygous and homo-
zygous mutants sampled at CT18. Of the five gels ana-
lyzed, 625 protein spots were reliably identified; of
these, 27 (4.3%) were consistently disregulated by a fac-
tor of 1.5 or more in the homozygous mutant. Of these,
20 were picked for identification by mass spectrometry
(16 downregulated and four upregulated in null mu-
tants), and three proteins (from six spots) previously
identified as being under circadian regulation were
found to be downregulated in the per2 mutant. These
three proteins were major urinary protein, selenium
binding protein (three isoforms), and peroxiredoxin. In
combination, therefore, our results demonstrate that
local rhythmic expression of circadian metabolic pro-
teins is dependent on an intact molecular clock.
Posttranscriptional and Translational Control
of Circadian Gene Expression
As noted above, transcriptomic analyses will not pro-
vide information concerning the contribution ofposttranscriptional mechanisms to circadian coordina-
tion. The role of such processes is emphasized by our
observation that individual genes yielded multiple,
rhythmic isoforms of particular proteins. In the cases
of Acaa2, Cat, and Serpina1, two isoforms were identi-
fied for each protein, whereas for Aldh2, the rhythmic
transcript generated three isoforms (Figure 2D; Table
S2). Interestingly, six different rhythmic Cps1 isoforms
were represented on our 2D gels. Moreover, they were
differentially phased: one held a daytime peak, whereas
the other five peaked at night, in the corresponding anti-
phase. Quantitative PCR confirmed that the transcripts
encoding Aldh2 and Cps1 were expressed rhythmically
in mouse liver (Figure 2D), with both peaking at the start
of circadian night and holding a variety of phase relation-
ships to their respective protein isoforms. These find-
ings demonstrate that posttranscriptional control is
a significant component in generating differentially
phased, and patterned, protein species. Moreover, this
temporal complexity of metabolic coordination is not
evident from transcriptomic profiling.
One likely form of posttranslational modification that
might also be expected to play a role in regulating tis-
sue-specific clock output is phosphorylation. To exam-
ine this further, we combined 2D-DIGE with phospho-
protein staining and observed that of the 36 rhythmic
spots for which phosphorylation state could be deter-
mined, 24 (67%) represented phospho-proteins. As an
example, we isolated concurrently two phosphorylated
forms of the same rhythmic protein, Peroxiredoxin 6
(Prdx6) (Figure 2E). This protein is a member of a recently
described family of highly conserved anti-oxidant pro-
teins [15, 16]. The isoforms carried different charges
and so segregated by iso-electric focusing. Although
we cannot exclude the possibility that a modification
other than phosphorylation caused the difference in
charge, it is plausible that this protein was differentially
phosphorylated in a circadian manner. Remarkably,
the two protein isoforms cycled in anti-phase, illustrat-
ing time-dependent post-translational modification of
Prdx6. Because Prdx6 mRNA also expressed a circadian
cycle in the liver and peaked around CT10 (Figure 2E),
one isoform was in phase with the transcript, and the
other was out of phase (as noted above for Cps1 iso-
forms, Figure 2D). Together, our data reveal that circa-
dian coordination of tissue function is more complex
than previously anticipated and occurs at multiple regu-
latory levels—transcriptional, posttranscriptional, and
posttranslational.
Marked Dissociation between the Circadian
Transcriptome and Proteome
Our implicit assumption was that these protein rhythms
originated from rhythmic transcriptional programmes,
and this view was supported for the three sets of pro-
tein isoforms and their corresponding mRNA profilesFigure 1. The Circadian Proteome of the Liver
(A) Circadian profiles of representative rhythmic proteins that fell into three broad phase clusters, each cluster represented by two separate plots
(left and right), with peaks in circadian night (upper four panels) or circadian daytime (lower two panels). Data are plotted as the mean value, with
all plots significant by ANOVA p < 0.01. CT0 data are replotted, and SEM is omitted for clarity (n = 3).
(B) Hierarchical clustering (by average distance correlation) of representative novel circadian proteins detected by 2D-DIGE. Green represents
low levels of protein expression, black represents intermediate levels, and red represents high levels of expression. Profiles for multiple 2D gel
spots representing isoforms of the same protein are indicated by parentheses.
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(A) Circadian profiles for Bmal1, Aldolase, Catalase and Arginase1 assayed by immunoblotting from wild-type livers.
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1111Figure 3. Comparison of Proteomic (2D-
DIGE) and Transcriptomic (qPCR) Assays of
Circadian Rhythmicity
(A) Comparison of three representative circa-
dian protein (black) and mRNA (red) profiles
for genes that are rhythmic at both transcrip-
tional and translational levels, with the mRNA
phase leading the protein phase.
(B) As in (A) but with simultaneous or delayed
mRNA peaks relative to the protein cycle.
(C) Circadian profiles for three representative
proteins whose mRNA is nonrhythmic.
All data are plotted as the mean +SEM, n = 6.
For protein profiles, p < 0.01; for mRNA cy-
cles in (A) and (B), p < 0.05. mRNA profiles
shown in (C) were not statistically significant
(p > 0.05).discussed above. We therefore tested this assumption
systematically, first by performing an in silico analysis
of data sets from several Affymetrix-based studies [6–
8] and thus comparing our cycling proteome with the
corresponding transcriptome in the liver. We were able
to obtain transcript data for 30 of our 39 genes that en-
coded rhythmic proteins. Unexpectedly, our analysis re-
vealed that the corresponding genes for only five rhyth-
mic proteins were also associated with a statistically
rhythmic mRNA, as reported by at least one of a number
of micro-array studies [5–8] (see Figure S1 and Table
S1). We subsequently conducted our own more exten-
sive statistical tests of archive RNA data from these in-
vestigations by utilizing spectral analysis and autocorre-
lation. These identified a number of further genes
(apoa4, hspa9a, and selenbp1) that were probably rhyth-
mically expressed, as well as others (akr1a, acaa2,
aldh2, arg1, ass1, cps1, eno1, gnpat, gstm1) that were
possibly rhythmic. These genes were potential false
negatives from the original transcriptomic screens for
circadian genes. Nevertheless, based on our stringent
reanalysis of available micro-array data, a possible 13
of 30 genes that encode rhythmic proteins were arrhyth-
mic at the RNA level.
Given that differences between each of the previous
micro-array studies (e.g., lighting conditions and mousegenetic backgrounds) may have accounted for discrep-
ancies both between the studies and between the tran-
scriptome and proteome, we used highly sensitive Taq-
man quantitative real-time PCR (qPCR) on the same
samples as our 2D-DIGE analysis in order to make a di-
rect comparison between the proteome and transcrip-
tome in a single sample set. We obtained profiles for
32 of our 39 target genes, and only 16 (50%) of these
tested genes that encode rhythmic proteins exhibited
statistically significant circadian variation in mRNA
levels. This included 8 of 12 ‘‘probable’’ or ‘‘possible’’
rhythmic genes from our initial statistical re-analysis of
micro-array data, thereby validating our current ANOVA
analysis of qPCR circadian data. In addition, the aldo2
and hspd1 transcripts, which were rhythmic in at least
one micro-array study, were not rhythmic by qPCR (Fig-
ures 3A and 3B; Table S2 and Figure S2A). Thus, at most
18 (16 + 2) of 32 target genes may be rhythmic, i.e., 56%.
Three main phase relationships between mRNA and
protein profiles were evident: (1) phase-advanced
mRNA relative to protein (e.g., ass1, aco2, aldh2,
bhmt, sdh1); (2) synchronous mRNA and protein profiles
(e.g., eef1d); and (3) phase-delayed mRNA relative to
protein (e.g., 0610038K03Rik, akr7a5, arg1, hspa9a).
Clearly, mRNA phase is not a strong predictor of protein
phase for circadian products in the liver. Moreover, for(B and C) Circadian expression of Bmal1, Arginase1, Aldolase, and Catalase in (B) wild-type (WT) but not clock mutant mice, as well as in (C)
circadian-competent heterozygous mPer2 mutants but not in homozygous mutant mice. Representative blots are shown. b-actin was used
as a loading control in all cases.
(D) Three distinct isoforms of Aldehyde dehydrogenase 2 (Aldh2) exhibited robust circadian protein profiles with a common phase, peaking in
circadian night. Cps1 was represented by six different forms, five of which peaked together in circadian night (here, these are represented by one
isoform [blue curve]: further isoforms are plotted in Figure 4A) and a sixth that peaked in anti-phase, in circadian day (red curve). Both Aldh2 and
Cps1 were encoded by highly rhythmic transcripts. All data aree plotted as the mean +SEM (n = 3 for proteins, n = 6 for mRNA).
(E) Two different forms of Prdx6 were identified by 2D-DiGE (boxed area). Staining with the ProQ Diamond phospho-stain showed them both to
be phosphorylated. The variants are identified here as red and blue circles on enlarged 2D-gel images and a three-dimensional plot. These two
forms of Prdx6 exhibited an anti-phasic oscillation, with one isoform (blue plot) peaking with the rhythmic mRNA and the second peaking 12 hr
later. All data are plotted as above.
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cally significant variation over the circadian cycle by
ANOVA (Figure 3C; Table S2 and Figure S2B). We cannot
of course exclude the possibility that distinct mRNA
pools may contribute differentially to translation. For ex-
ample, more recently synthesized and cyclical mRNA
may drive rhythmic protein expression against a back-
ground of a larger and older nonrhythmic mRNA pool.
Such a mechanism would involve an intriguing and un-
precedented complexity in the circadian regulation of
gene expression. Nevertheless, our findings show that
our initial expectation that rhythmic proteins would
have an underlying rhythmic mRNA profile, i.e., rhyth-
micity begets rhythmicity, was misguided. More impor-
tantly, it highlights for the first time that posttranscrip-
tional mechanisms must exert significant control over
circadian coordination in vivo.
To determine mechanisms that may account for the
differences in the behavior of mRNA and proteins, we
first looked for binding sites within the 50-flanking re-
gions of genes coding rhythmic and nonrhythmic
mRNAs and found that although a variety of circadian el-
ements were present (E box, E0 box, D box and RORE),
they were equally likely to occur in either group (see Ta-
ble S2). This suggests that control of promoter activity
by known circadian elements is unlikely to explain the
observed variance in mRNA rhythmicity [17]. How might
nonrhythmic mRNA result in rhythmic protein expres-
sion? Translational control of circadian expression has
been observed previously for a limited number of circa-
dian proteins in lower organisms, but not in mammals,
and not to the extent seen here. For example, in the di-
noflagellate Gonyaulax polyedra, luciferin binding pro-
tein (LBP) mRNA is not rhythmic, but protein expression
(and bioluminescence) exhibits clear circadian oscilla-
tion mediated by the rhythmic binding activity of the
RNA binding protein CCTR to the LBP 30UTR [18].
Similarly, rhythmic expression of the deadenylase, noc-
turnin, in the Xenopus retina may potentially regulate
steady-state downstream target mRNAs to generate
protein cycles [19, 20]. Such mechanisms involving
RNA binding proteins and their interactions with target
UTRs could explain the patterns we observed in mouse
liver. Our results thus highlight the role that posttran-
scriptional mechanisms, which have hitherto received
little attention, undoubtedly possess in exerting signifi-
cant control over the circadian proteome.
Circadian Control of Critical Liver Processes:
Ureagenesis and Sugar Metabolism
Because we focused on soluble proteins, the circadian
proteins we found were predominantly enzymes. Impor-
tantly, they are associated with a variety of vital liver
functions, and here we focus on two archetypal path-
ways: urea formation and sugar metabolism. Urea for-
mation is a central function of the liver, and three distinct
proteins that control three independent steps in the urea
cycle (Carbamoyl phosphate synthetase 1, Cps1; Argi-
nosuccinate synthetase 1, Ass1; and Arginase 1, Arg1)
were revealed as robustly rhythmic (Figure 4A). The ac-
tivity of Arg1 has been shown previously to vary across
the circadian cycle in the liver [21], consistent with our
findings here, whereas circadian rhythmicity has not
been reported previously for the activity or abundanceof either Cps1 or Ass1. Importantly, Cps1 acts at the
rate-limiting step in ureagenesis by converting ammonia
to carbamoyl phosphate; mice genetically deficient in
Cps1 die in early development because of an accumula-
tion of excess ammonia [22], and mutations in cps1 are
associated with liver disorders in humans [23]. The rela-
tive phasing of these proteins may be significant, insofar
as Ass1 and the majority of Cps isoforms peaked during
circadian night when nocturnal feeding and digestion
would present amino acids to the hepatocytes, whereas
Arg1, the final stage before urea production peaked later
in circadian day, when digestion would have been com-
plete.
Several enzymes involved in sugar metabolism were
also under circadian control. First, Ketohexokinase
and Succinate dehydrogenase 1, both involved in the
fructose metabolism pathway, upstream of glycolysis,
exhibited highly rhythmic protein oscillations (Figure 4B).
Second, we found that two key glycolytic enzymes, Al-
dolase 2 and Enolase 1, showed robust rhythmic ex-
pression, as did Aconitase 2, which catalyses the con-
version of citrate to isocitrate in the second step of the
citric acid (tricarboxylic acid) cycle. All five of these en-
zymes exhibited synchronous oscillation, with expres-
sion levels increasing through the circadian night (Fig-
ure 4B). Previous studies have generally shown that
transcription of genes encoding metabolic enzymes
in this pathway peaks at the onset of circadian night
[5, 6], in anticipation of the initiation of nocturnal feeding.
The current results demonstrate synchronous activation
of a suite of proteins critical to carbohydrate metabo-
lism. Such temporal regulation likely optimises hepatic
processing of nocturnal meals and metabolic efficiency
in general.
Discussion
Our integration of proteomic and transcriptomic analy-
ses adds a new perspective to the understanding of cir-
cadian coordination in the liver and is the first study to
assess posttranscriptional regulation in this context.
We have revealed extensive and divergent rhythmic
control of protein expression, such that the liver pro-
teome is markedly different between circadian day and
night. This temporal regulation involves up to 20% of
the soluble proteins we were able to detect and high-
lights circadian control of a variety of archetypal and vi-
tal liver-specific processes, including rate-limiting steps
in urea, sugar, alcohol and bile acid metabolism. The
physiological relevance of circadian changes in the pro-
teome should not, therefore, be underestimated, in that
they are as extensive and robust as those described in
pathological conditions. For example, using similar
methodology, Fella et al. (2005) recently showed that
chemically induced liver carcinogenesis is associated
with differential expression of approximately 7.5% of
liver proteins [24].
This natural and regular daily change in protein com-
position is likely to be common to many tissues and
thus provides a framework for understanding various re-
ports of severe metabolic disturbance both in circadian
mutant mice [1, 25] and in humans subject to shift
work [2, 26]. In the specific context of hepatic function,
circadian variation may have numerous adaptive
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1113Figure 4. Circadian Coordination of Rate-Limiting Proteins in Vital Hepatic Pathways
(A) A schematic view of the urea cycle illustrates roles of circadian proteins and accompanying representative circadian profiles of Carbamoyl-
phosphate synthetase 1 (Cps1, blue), Arginosuccinate synthetase 1 (Ass1, pink) and Arginase 1 (Arg1, green). Data are plotted as mean + SEM,
n = 3. Two different isoforms of Cps1 are plotted; Cps1 (4) (dark blue, dotted line) and Cps1 (5) (pale blue). Further isoforms of Cps1 are plotted
in Figure 2.
(B) Circadian profiles of proteins involved in carbohydrate metabolism at levels of fructose metabolism (Ketohexokinase [Khk], Succinate dehy-
drogenase 1 [Sdh1]), glycolysis (Aldolase 2 [Aldo2], Enolase 1 [Eno1]), and the TCA cycle (Aconitase 2 [Aco2]). All five proteins underwent syn-
chronous oscillation, with troughs of expression in the middle of the circadian day, and peaked to coincide with the feeding phase at night. Data
are plotted as above.physiological roles. For example, changes in expression
of circadian-regulated liver genes underlie the ability to
switch metabolic fuels during environmental stress
[27], and its pathological relevance is evident from the
observation that an inability to metabolise nutrients as
a result of inappropriate meal-times may be a majorcause of coronary heart disease in shift workers [28].
Our findings also provide a mechanistic framework
within which one can understand temporal aspects of
toxicology and drug metabolism, for example, in the cir-
cadian pattern of vulnerability to cytotoxic agents [29].
Further characterization of the circadian proteome will
Current Biology
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could facilitate more effective chrono-therapeutic strat-
egies.
An unprecedented finding is that for almost one half of
the rhythmic proteins, their corresponding mRNA was
not rhythmic. Analogous dissociations between expres-
sion changes in the transcriptome and proteome have
recently been observed in models of cancer and other
diseases [9, 10], further illustrating the utility of taking
an integrated view of circadian gene expression. A vari-
ety of kinases are known to influence the period of the
core circadian clockwork by altering the stability of Pe-
riod and associated proteins in rodents and humans
[4, 31] and thus targeting their degradation by the pro-
teosome. Such kinases may play a more general role
in sculpting the circadian proteome reported here.
Equally, temporally specific metabolism of RNA may un-
derlie some of these daily patterns, and the deadenylase
Nocturnin is a clock-regulated factor [19] that offers
a precedent for such a mechanism [20]. Elucidating the
posttranscriptional and translational control points that
regulate circadian protein oscillations therefore remains
a critical step in characterizing the molecular pro-
grammes that drive circadian physiology and disease.
The combined proteomic and transcriptomic analyses
developed here offer an effective framework for under-
standing how local and central clock mechanisms gen-
erate appropriately timed daily metabolic programmes.
Supplemental Data
Supplemental data include Experimental Procedures, two figures,
and two tables and are available with this article online at http://
www.current-biology.com/cgi/content/full/16/11/1107/DC1/.
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